Enzyme Kinetics & Regulation
Overview
Most treatments of enzyme kinetics stop at one equation. This page goes further: it derives where the Michaelis-Menten equation comes from, what its two parameters actually mean mechanistically, and β the part that dominates real olympiad questions β how each of the four modes of reversible inhibition distorts those parameters differently. All four inhibition types are describable with a small, reusable algebraic toolkit once you understand where the Ξ± and Ξ±β² factors come from.
Key Concepts
The basic reaction scheme and two kinetic regimes
The minimal single-substrate enzyme reaction is:
$$ \text{E} + \text{S} \underset{k_{-1}}{\overset{k_1}{\rightleftharpoons}} \text{ES} \underset{}{\overset{k_2}{\rightarrow}} \text{E} + \text{P} $$
Pre-steady-state kinetics (milliseconds to seconds, [E] typically in excess, rapid mixing) probes the individual rate/equilibrium constants (kβ, kββ, kβ) directly, before the system reaches a stable intermediate concentration. This regime is out of syllabus depth for most olympiads but worth recognising by name.
The shaded region marks the brief pre-steady-state phase; steady state (d[ES]/dt = 0) is the much longer window steady-state kinetics actually measures. Source: unattributed, sourced pre-existing site asset.
Steady-state kinetics assumes the rate of ES formation equals its rate of breakdown β [ES] stays approximately constant even as [S] and [P] change:
$$ k_1([E_t] - [ES])[S] = k_{-1}[ES] + k_2[ES] $$
Solving for [ES] and substituting into rate = kβ[ES] yields the central result:
where $K_m = \dfrac{k_{-1} + k_2}{k_1}$. Note that if product release (kβ) is rate-limiting, $K_m = K_d = k_{-1}/k_1$ β i.e. $K_m$ collapses to the true substrate dissociation constant, and can be read directly as (an inverse measure of) binding affinity. This equivalence does not hold in general β only when kβ is rate-limiting.
V_max, k_cat, and the specificity constant
$V_{max} = k_{cat}[E_t]$, where $k_{cat}$ (the turnover number) is the rate constant of the overall rate-limiting step β in the minimal scheme above, $k_{cat} = k_2$. For a three-step scheme $\text{E+S} \rightleftharpoons \text{ES} \rightleftharpoons \text{EP} \rightleftharpoons \text{E+P}$ with product release limiting, $k_{cat} = k_3$. $k_{cat}$ represents substrate molecules converted to product per unit time per enzyme molecule when the enzyme is fully saturated.
At low [S] (specifically [S] βͺ $K_m$), the Michaelis-Menten equation reduces to:
$$ V_0 = [E_t] \cdot [S] \cdot \frac{k_{cat}}{K_m} $$
The ratio k_cat/K_m, the specificity constant, is the best single number for comparing catalytic efficiency across different enzymes or different substrates of the same enzyme β it is a second-order rate constant (units Mβ»ΒΉsβ»ΒΉ) describing the E + S β E + P conversion as a whole. There is a physical ceiling on this ratio: the diffusion-controlled limit, ~10βΈβ10βΉ Mβ»ΒΉsβ»ΒΉ, set by how fast E and S can encounter each other in solution. Enzymes approaching this limit are said to have achieved catalytic perfection β they convert essentially every productive encounter into product.
Enzymes for which kκββ/Kβ approaches the diffusion-controlled limit (10βΈβ10βΉ Mβ»ΒΉsβ»ΒΉ):
| Enzyme | Substrate | kκββ (sβ»ΒΉ) | Kβ (M) | kκββ/Kβ (Mβ»ΒΉsβ»ΒΉ) |
|---|---|---|---|---|
| Acetylcholinesterase | Acetylcholine | 1.4 Γ 10β΄ | 9 Γ 10β»β΅ | 1.6 Γ 10βΈ |
| Carbonic anhydrase | COβ | 1 Γ 10βΆ | 1.2 Γ 10β»Β² | 8.3 Γ 10β· |
| Carbonic anhydrase | HCOββ» | 4 Γ 10β΅ | 2.6 Γ 10β»Β² | 1.5 Γ 10β· |
| Catalase | HβOβ | 4 Γ 10β· | 1.1 Γ 10β° | 4 Γ 10β· |
| Crotonase | Crotonyl-CoA | 5.7 Γ 10Β³ | 2 Γ 10β»β΅ | 2.8 Γ 10βΈ |
| Fumarase | Fumarate | 8 Γ 10Β² | 5 Γ 10β»βΆ | 1.6 Γ 10βΈ |
| Fumarase | Malate | 9 Γ 10Β² | 2.5 Γ 10β»β΅ | 3.6 Γ 10β· |
| Ξ²-Lactamase | Benzylpenicillin | 2.0 Γ 10Β³ | 2 Γ 10β»β΅ | 1 Γ 10βΈ |
Data: Fersht, A. (1999). Structure and Mechanism in Protein Science, p. 166, W. H. Freeman and Company. (Redrawn as a table rather than reproduced as a textbook scan β the underlying rate constants are data, not the copyrighted expression.)
Worked example. An enzyme “happyase” catalyses SAD β HAPPY, with $k_{cat} = 600\ \text{s}^{-1}$. At $[E_t] = 20\ \text{nM}$ and $[\text{SAD}] = 40\ \mu\text{M}$, $V_0 = 9.6\ \mu\text{M s}^{-1}$. Find $K_m$.
First, $V_{max} = k_{cat}[E_t] = 600\ \text{s}^{-1} \times 0.020\ \mu\text{M} = 12\ \mu\text{M s}^{-1}$. Using the ratio form:
$$ \frac{V_0}{V_{max}} = \frac{[S]}{K_m + [S]} ;\Rightarrow; \frac{9.6}{12} = \frac{40}{K_m + 40} ;\Rightarrow; 0.8(K_m + 40) = 40 ;\Rightarrow; K_m = 10\ \mu\text{M} $$
This ratio shortcut ($V_0/V_{max}$ instead of solving the full equation from scratch) is faster under exam time pressure than substituting directly into the Michaelis-Menten form.
Reading Michaelis-Menten and Lineweaver-Burk plots
The Michaelis-Menten plot ($V_0$ vs. $[S]$) is hyperbolic: near-linear (first-order) at low $[S]$, plateauing toward $V_{max}$ (zero-order) at high $[S]$; $K_m$ is the $[S]$ at which $V_0 = V_{max}/2$.
The defining hyperbolic shape β v rises steeply at low [S], then plateaus toward V as [S] grows. Km is read directly off the curve at v = 0.5V. Source: unattributed, sourced pre-existing site asset.
Taking the reciprocal linearises the relationship β the Lineweaver-Burk (double-reciprocal) plot:
Slope = $K_m/V_{max}$, y-intercept = $1/V_{max}$, x-intercept = $-1/K_m$. Its main use is diagnostic: the direction each inhibition type shifts the slope, y-intercept, and x-intercept is what actually distinguishes the four inhibition modes below (see Comparative Structures).
Real data scatters more at high 1/[S] (i.e. low, less reliable [S] measurements) β a caveat worth knowing even though the straight-line form is what makes the plot useful for reading off Km/Vmax by eye. Source: unattributed, sourced pre-existing site asset.
The four modes of reversible inhibition
All four share the same underlying trick: expressing the new, “apparent” parameters as the original parameter times a modification factor built from $[I]/K_I$.
Seeing all four on the same v-vs-[S] axes makes the pattern easier to hold onto than the equations alone: watch which curves still reach the original Vmax (competitive, at high enough [S]) and which are capped below it (the other three). Source: unattributed, sourced pre-existing site asset.
Competitive inhibition β inhibitor binds free E only, at (or overlapping) the substrate site, so E and I compete directly:
$$ \text{E} + \text{I} \rightleftharpoons \text{EI} \qquad V_0 = \frac{V_{max}[S]}{K_m \cdot \alpha + [S]}, \quad \alpha = 1 + \frac{[I]}{K_I} $$
Apparent $K_m’ = K_m \cdot \alpha$ (increases β looks like lower substrate affinity); $V_{max}$ is unchanged, because enough substrate can always out-compete the inhibitor.
Derivation sketch: mass balance $[E_t] = [E] + [ES] + [EI]$, with $[EI] = [E][I]/K_I$, substituted through the steady-state $[ES] = [E][S]/K_m$ relation, collapses to $V_0 = \dfrac{V_{max}[S]}{K_m(1+[I]/K_I) + [S]}$ β matching the boxed result above with $K_m^{app} = K_m\alpha$.
Uncompetitive inhibition β inhibitor binds only the ES complex, not free E:
$$ \text{ES} + \text{I} \rightleftharpoons \text{EIS} \qquad K_m’ = \frac{K_m}{\alpha’}, \quad V_{max}’ = \frac{V_{max}}{\alpha’}, \quad \alpha’ = 1 + \frac{[I]}{K_I’} $$
Both parameters decrease by the same factor β because binding is blocked from converting to product, the apparent affinity increases (lower $K_m’$) even as maximum output falls.
Noncompetitive inhibition β inhibitor binds both E and ES with equal affinity (both reactions below occur, with the same $K_I$):
$$ \text{E} + \text{I} \rightleftharpoons \text{EI}, \qquad \text{ES} + \text{I} \rightleftharpoons \text{EIS} $$
Only $V_{max}$ decreases (by factor Ξ±); $K_m$ is unchanged, because inhibitor binding doesn’t discriminate between free and substrate-bound enzyme.
Mixed inhibition β the general case: inhibitor binds both E and ES, but with different affinities ($K_I \neq K_I’$). Both $K_m$ and $V_{max}$ change, and $K_m$ can move in either direction depending on which affinity dominates:
$$ K_m’ = K_m \cdot \frac{\alpha}{\alpha’}, \qquad V_{max}’ = \frac{V_{max}}{\alpha} $$
Irreversible inhibition is chemically distinct from all four above: it forms a covalent bond to the enzyme (as opposed to the non-covalent binding underlying reversible inhibition), so it cannot be diluted or out-competed away. Most toxins and many drug mechanisms (e.g. aspirin on COX, some antibiotics on transpeptidases) work this way.
Comparative Structures
The fastest way to identify an inhibition type from data (a Lineweaver-Burk plot or a $K_m$/$V_{max}$ table) is this signature table:
| Inhibition type | Binds | $K_m$ | $V_{max}$ | LB slope | LB y-intercept | LB x-intercept |
|---|---|---|---|---|---|---|
| Competitive | E only | β | unchanged | β | unchanged | shifts toward 0 |
| Uncompetitive | ES only | β | β (same factor) | unchanged | β | shifts (same factor as $K_m$) |
| Noncompetitive | E and ES equally | unchanged | β | β | β | unchanged |
| Mixed | E and ES unequally | β or β | β | changes | β | changes |
| Irreversible | E or ES, covalently | effectively β (fewer active enzymes) | β | β | β | β (behaves like a shrinking $[E_t]$, not a classic reversible signature) |
This is the figure to memorise for “identify the inhibition type from this plot” questions β the intersection point (or lack of one) alone distinguishes all four types, matching the LB columns of the table above exactly. Source: unattributed, sourced pre-existing site asset.
Common Exam Questions
- “Given this Lineweaver-Burk shift, identify the inhibition type” β read the y-intercept and slope changes, not just whether the line moved; competitive and noncompetitive both raise the slope but differ in whether the y-intercept moves.
- “Does adding more substrate overcome this inhibitor?” β only for competitive inhibition (and, up to a point, mixed); never for pure noncompetitive or uncompetitive, since $V_{max}$ itself is capped lower.
- Distinguishing irreversible inhibition from noncompetitive inhibition when they produce the same final $K_m$/$V_{max}$ values requires a kinetic (not just an endpoint) argument: dilution or dialysis restores activity for reversible noncompetitive inhibition but not for a covalently bound irreversible inhibitor.
- “What does $k_{cat}/K_m$ near the diffusion limit imply?” β catalytic perfection, i.e. essentially every diffusion-limited encounter between E and S is productive.
Visual Reference
Interactive
- An interactive Michaelis-Menten/Lineweaver-Burk plot: sliders for $[I]$, $K_I$, $K_I’$, with a toggle between the four inhibition modes, redrawing both plots live β a natural upgrade from the static plots below, since the whole point of this topic is seeing how the curves shift.
Static
(Placed inline above: the kinetic phases diagram, the Table 6-8 specificity-constant reference, the Michaelis-Menten and Lineweaver-Burk plots, and the two four-inhibition-type comparison figures.)
Practice Problems
1. How would you experimentally distinguish irreversible inhibition from noncompetitive inhibition if both produce identical $K_m$ and $V_{max}$ values at a fixed inhibitor concentration?
Show answer
Dilute the enzyme-inhibitor mixture substantially, or dialyse away free/loosely-bound inhibitor, then reassay. Noncompetitive (reversible) inhibition is concentration-dependent and non-covalent, so activity recovers as $[I]_{effective}$ drops. Irreversible inhibition is covalent β the inhibited fraction of enzyme stays inhibited regardless of dilution, so activity does not recover proportionally; only newly synthesised, never-exposed enzyme contributes to any recovery.
2. An enzyme has $K_m = 20\ \mu M$ and $k_{cat} = 400\ s^{-1}$ in the absence of inhibitor. Adding a fixed concentration of a competitive inhibitor changes the apparent $K_m$ to $60\ \mu M$. What is $\alpha$, and what does it tell you about $[I]/K_I$ at this concentration?
Show answer
$\alpha = K_m^{app}/K_m = 60/20 = 3$. Since $\alpha = 1 + [I]/K_I$, this gives $[I]/K_I = 2$ β the inhibitor concentration is twice its own dissociation constant at this point.
3. Sketch (conceptually) how the Lineweaver-Burk plot changes as increasing concentrations of a mixed inhibitor with $K_I \ll K_I’$ (much stronger binding to free E than to ES) are added. Which pure inhibition type does this mixed case approach in the limit?
4. An enzyme’s specificity constant $k_{cat}/K_m$ measured for two substrates differs by 100-fold, yet both substrates give the same $V_{max}$ when saturating. Explain how this is possible, and identify which kinetic parameter must differ between the two substrates.